← All trials
NCT03199417
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2017
- Primary completion
- Jul 31, 2019
- Completion date
- Dec 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 186
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of MichiganLead sponsor
- University of MichiganReponsible party - principal investigator
- McMaster UniversityCollaborator
- McMaster UniversityOverall official - principal investigator
- Oakville Trafalgar Memorial HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.